Bellerophon prices $7M follow-on

Cardiopulmonary disease company Bellerophon Therapeutics Inc. (NASDAQ:BLPH) raised $7 million through the sale of 10 million shares at $0.70 in a follow-on on Jan. 23. The price is a 20% discount to Bellerophon's close of $0.88 on Jan. 22, before the company announced the offering...